The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,774.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Eurozone recession and Barclays slide quash gain

Fri, 30th Apr 2021 12:13

(Alliance News) - Friday's positive start in London waned as the morning progressed, with Barclays shares falling and the eurozone entering a double-dip recession.

The FTSE 100 index was just 0.48 of a point lower at 6,961.00 at midday. The mid-cap FTSE 250 index was down 13.58 points, or 0.1%, at 22,379.36. The AIM All-Share index was down 0.2% at 1,271.99.

The Cboe UK 100 index was up flat at 692.90. The Cboe 250 was down 0.1% at 20,021.97, and the Cboe Small Companies up 0.4% at 14,660.35.

In mainland Europe, the CAC 40 in Paris was down 0.2%, while the DAX 30 in Frankfurt was 0.3% higher.

After a green start to Friday, the mood was darkened by figures showing the eurozone economy shrank at the start of 2021 and the bloc entered into a double-dip recession.

Eurozone gross domestic product contracted 0.6% quarter-on-quarter for the first three months of 2021, following a 0.7% decline in the fourth quarter of 2020. The latest reading was slightly better than expectations, according to FXStreet, of a 0.8% decline.

A technical recession is two consecutive quarters of GDP decline. The eurozone entered a technical recession after the second quarter print for 2020 showed a quarter-on-quarter slump of 12% after a 3.6% fall in the first three months of the year, but the bloc rebounded strongly in the third quarter of the year with growth of 13%.

Germany, the eurozone's largest economy, saw GDP shrink 1.7% in the first three months of 2021 on a sequential basis, while France fared slightly better as its economy grew 0.4%.

Pantheon Macroeconomics said the main hit to eurozone growth came from the drop in Germany.

However, Pantheon's chief eurozone economist, Claus Vistesen, commented: "We are sticking to our forecast that Q2 in the EZ as a whole will be better. We look for reopening in the latter part of the quarter, before a more sustained upturn in H2. As it stands, this also means that we are now more confident that EZ GDP will increase by close to 4% this year, in contrast to our previous expectation of a 3.5% increase.

"This number, however, is at the mercy of the pace of the still-unpredictable post-reopening rebound."

The euro traded at USD1.2096 following the figures, falling from USD1.2120 late Thursday.

Sterling was quoted at USD1.3914 on Friday, down on USD1.3950 at the London equities close on Thursday. Against the yen, the dollar fell to JPY108.87 on Friday versus JPY108.94 late Thursday.

Gold was quoted at USD1,769.34 an ounce, slightly up on USD1,768.68 on Thursday. Brent oil was trading at USD67.70 a barrel, down from USD68.35 late Thursday.

Wall Street was on track for a lower open on Friday, with the Dow Jones called down 0.3%, the S&P 500 down 0.4% and the Nasdaq Composite down 0.6%.

Twitter shares are likely to weigh on the Nasdaq index, trading 12% lower pre-market after the micro-blogging platform warned that user growth could slow in the coming quarters as activity seen during the coronavirus pandemic fades.

For the first quarter to March 31, revenue was up 28% at USD1.04 billion from USD807.6 million a year before and net income at USD68.01 million, swinging from a loss of USD8.40 million. However, the company cautioned that the "significant pandemic-related surge we saw last year" creates challenging comparatives going forward.

The market reacted better to Amazon's results, the stock trading 2.1% higher ahead of the New York open as its net income more than tripled for the first quarter of 2021, driven by double-digit growth in sales from all regions. For the three months ended March 31, the Seattle, Washington-based technology and e-commerce behemoth posted net income of USD8.11 billion, up sharply from USD2.54 billion the prior year.

In London, shares in lender Barclays were weighing on the FTSE 100 after its first-quarter results.

"The decision not to adjust its previous bad debt estimates, unlike most of its peer group, appears to have spooked the market along with a patchy investment banking performance and a cautious view on costs as Barclays looks at reducing its physical footprint," said Russ Mould, investment director at AJ Bell.

The stock traded 5.6% lower despite a record quarterly profit figure as credit impairment charges were reduced. However, Barclays saw income drop following a disappointing period for the cards and UK businesses.

Pretax profit was a "record" GBP2.40 billion for the first quarter of 2021, up sharply from GBP913 million a year ago. Credit impairment charges were cut by 97% to GBP55 million from GBP2.12 billion.

The bank's high street division had a mixed period as the recent lockdowns reduced consumer spending, but the stamp duty holiday continued to help the housing market and its mortgage division. Barclays UK income fell 8% to GBP1.58 billion.

At the top of the index were Smurfit Kappa, up 3.8%, and AstraZeneca, rising 3.5%.

Packaging firm Smurfit Kappa said underlying revenue rose 6% to EUR2.27 billion in the first three months of the year. Earnings before interest, tax, depreciation and amortisation were 1.6% higher year-on-year at EUR386 million from EUR380 million.

AstraZeneca, meanwhile, posted a hike in first quarter earnings as it said it generated USD275 million in Covid-19 vaccine sales.

The jab's use has been restricted by age in many countries over links to rare blood clots - with this also listed as a side effect for the Johnson & Johnson Covid-19 vaccine - but regulatory agencies have stressed that the benefits outweigh the risks.

AstraZeneca's revenue in the first quarter of 2021 jumped 15% to USD7.32 billion from USD6.35 billion a year earlier. Pretax profit climbed 72% to USD1.61 billion from USD935 million.

"Against the backdrop of a global pandemic and GSK's recent lacklustre earnings, AstraZeneca appears to be setting the benchmark for success amongst the world's big pharma' players," said Sebastian Skeet, senior analyst at Third Bridge.

GlaxoSmithKline shares ended flat after the release of its own quarterly results on Wednesday, as the pharma peer reported a 18% fall in revenue and 16% drop in operating profit. Glaxo was up 0.5% on Friday.

In the FTSE 250, Diversified Gas & Oil shares rose 3.7%. The energy producer and distributor said it is expanding its operations into a new region with the USD135 million acquisition of upstream assets in Louisiana and Texas.

The company is buying around 780 wells producing 16,000 barrels of oil equivalent per day from Indigo Minerals. The assets in the Cotton Valley area are Diversified's first outside the Appalachia region.

Elsewhere, Darktrace shares were trading more than 40% above its IPO price on its debut in London.

The UK tech startup, founded in 2013, provides cybersecurity services to businesses using artificial intelligence.

Sky News last week reported that Darktrace was cutting the value of its initial public offering to avoid a repeat of Deliveroo's calamitous float - a plan that appears to have worked out as Darktrace traded at 358.25p on Friday, well above its IPO price of 250p and turning its GBP1.7 billion market capitalisation on admission into a GBP2.5 billion valuation.

"Given the sharp boost in initial trading there will inevitably be some criticism that the listing was priced too low, however given what happened with Deliveroo maybe expectations were adjusted lower by a little too much," said CMC Market's Michael Hewson.

Even with a market capitalisation of just GBP1.7 billion, Darktrace would comfortably slip into the FTSE 250 in the next quarterly index review. Unconditional dealings begin on May 6.

Deliveroo shares were trading at 263.74p on Friday, still well below its IPO price of 390p.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
9 Oct 2023 07:42

LONDON BRIEFING: Metro Bank secures deal to shore up finances

(Alliance News) - Stocks in London are set to open higher on Monday as interest rate expectations held steady despite Friday's bumper US nonfarm payrolls report.

Read more
9 Oct 2023 07:20

GSK inks deal to promote shingles vaccine in China

(Sharecast News) - GSK has entered into a new exclusive vaccine partnership in China that will extend the availability of its shingle vaccine Shingrix, which will see the UK-listed group generate £2.5bn over the next three years.

Read more
8 Oct 2023 11:36

Sunday newspaper round-up: Renewi, Metro Bank, New homes

(Sharecast News) - Some of Renewi's major shareholders are divided as to whether the recycling company should engage with Australian suitor Macquarie. One major shareholder has told Renewi's board that it should not until Macquarie raised its £636m bid, but another top ten shareholder told The Sunday Times that it should talk to the Australian outfit anyways. Macquarie has until 26 October to make a firm offer. - The Sunday Times

Read more
6 Oct 2023 08:17

GSK raises £885.6m from Haleon share sale

(Sharecast News) - GSK said on Friday that it has sold 270m shares in Haleon - the consumer health business it spun off last year - raising around £885.6m.

Read more
6 Oct 2023 07:57

UPDATE: GSK banks GBP886 million from Haleon share sale

(Alliance News) - GSK PLC on Friday said it received GBP885.6 million in gross proceeds from its sale of shares in consumer healthcare spin-off Haleon PLC.

Read more
6 Oct 2023 07:46

LONDON BRIEFING: Wetherspoon swings to profit; UK house prices fall

(Alliance News) - Stocks in London are called to open higher on Friday, as investors eye a key nonfarm payroll reading in the US.

Read more
5 Oct 2023 15:47

UK dividends calendar - next 7 days

Friday 6 October 
Admiral Group PLCdividend payment date
Alfa Financial Software Holdings PLCspecial dividend payment date
Anglo-Eastern Plantations PLCdividend payment date
Blackrock World Mining Trust PLCdividend payment date
Cairn Homes PLCdividend payment date
Dalata Hotel Group PLCdividend payment date
Drax Group PLCdividend payment date
Glanbia PLCdividend payment date
GlobalData PLCdividend payment date
Goodwin PLCdividend payment date
Greggs PLCdividend payment date
Intertek Group PLCdividend payment date
Irish Continental Group PLCdividend payment date
JPMorgan American Investment Trust PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Land Securities Group PLCdividend payment date
Personal Assets Trust PLCdividend payment date
Quartix Technologies PLCdividend payment date
Serco Group PLCdividend payment date
Walker Crips Group PLCdividend payment date
Warehouse REIT PLCdividend payment date
Zotefoams PLCdividend payment date
Monday 9 October 
Henderson Smaller Cos Investment Trust PLCdividend payment date
LondonMetric Property PLCdividend payment date
Tuesday 10 October 
LSL Property Services PLCdividend payment date
Wednesday 11 October 
Assura PLCdividend payment date
Rathbones Group PLCdividend payment date
Thursday 12 October 
Blackrock Latin American Investment Trust PLCex-dividend payment date
Breedon Group PLCex-dividend payment date
Diageo PLCdividend payment date
GSK PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
Invesco Bond Income Plus Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Mid Cap Investment Trust PLCex-dividend payment date
Kingfisher PLCex-dividend payment date
MP Evans Group PLCex-dividend payment date
Macfarlane Group PLCdividend payment date
North American Income Trust PLCex-dividend payment date
Oxford Instruments PLCdividend payment date
Persimmon PLCex-dividend payment date
Personal Group Holdings PLCex-dividend payment date
Primary Health Properties PLCex-dividend payment date
Ruffer Investment Co Ltdex-dividend payment date
Senior PLCex-dividend payment date
Spirax-Sarco Engineering PLCex-dividend payment date
Strategic Equity Capital PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Taylor Wimpey PLCex-dividend payment date
Tesco PLCex-dividend payment date
TT Electronics PLCdividend payment date
WPP PLCex-dividend payment date
XP Power Ltddividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Oct 2023 18:19

IN BRIEF: GSK's Jemperli approved in UK for endometrial cancer

GSK PLC - London-based pharmaceutical company - On Monday, announces that the UK Medicines & Health Products Regulatory Agency has authorised a new indication for Jemperli, also known as dostarlimab. The drug is used as a treatment for some types of endometrial cancer and an be used to treat patients that have a tumour abnormality called mismatch repair deficient/microsatellite instability-high when the cancer is at an advanced stage when first diagnosed or has returned after previous treatment. It is now authorised to be used together with chemotherapy to slow the progression of these cancers. GSK says it is the first medicine licensed as first line treatment for primary advanced or recurrent endometrial cancer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 08:37

TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.

Read more
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.